[Treatment of inoperable breast cancer].
Osaki A, Nakamiya N, Saeki T, Matsuura K.
Nihon Rinsho. 2012 Sep;70 Suppl 7:581-6. Japanese. No abstract available.
PMID:23350467

Randomized phase II study of three doses of oral TAS-108 in postmenopausal patients with metastatic breast cancer.
Inaji H, Iwata H, Nakayama T, Yamamoto N, Sato Y, Tokuda Y, Aogi K, Saji S, Watanabe K, Saito T, Yoshida M, Sato N, Saeki T, Takatsuka Y, Kuranami M, Yamashita H, Kikuchi A, Tabei T, Ikeda T, Noguchi S.
Cancer Sci. 2012 Sep;103(9):1708-13. doi: 10.1111/j.1349-7006.2012.02354.x. Epub 2012 Jul 16.
PMID:22676245

Axillary ultrasound examination is useful for selecting patients optimally suited for sentinel lymph node biopsy after primary systemic chemotherapy.
Shigekawa T, Sugitani I, Takeuchi H, Misumi M, Nakamiya N, Sugiyama M, Sano H, Matsuura K, Takahashi T, Fujiuchi N, Osaki A, Saeki T.
Am J Surg. 2012 Oct;204(4):487-93. doi: 10.1016/j.amjsurg.2011.09.026. Epub 2012 Apr 5.
PMID:22483167

Association of double-positive FOXA1 and FOXP1 immunoreactivities with favorable prognosis of tamoxifen-treated breast cancer patients.
Ijichi N, Shigekawa T, Ikeda K, Horie-Inoue K, Shimizu C, Saji S, Aogi K, Tsuda H, Osaki A, Saeki T, Inoue S.
Horm Cancer. 2012 Aug;3(4):147-59. doi: 10.1007/s12672-012-0111-0. Epub 2012 Apr 3.
PMID:22476979

A multicenter phase II study of TSU-68, an oral multiple tyrosine kinase inhibitor, in combination with docetaxel in metastatic breast cancer patients with anthracycline resistance.
Toi M, Saeki T, Iwata H, Inoue K, Tokuda Y, Sato Y, Ito Y, Aogi K, Takatsuka Y, Arioka H.
Breast Cancer. 2014 Jan;21(1):20-7. doi: 10.1007/s12282-012-0344-3. Epub 2012 Mar 2.
PMID:22382811

18F-fluorodeoxyglucose positron emission tomography optimizes neoadjuvant chemotherapy for primary breast cancer to achieve pathological complete response.
Ueda S, Saeki T, Shigekawa T, Omata J, Moriya T, Yamamoto J, Osaki A, Fujiuchi N, Misumi M, Takeuchi H, Sakurai T, Tsuda H, Tamura K, Ishida J, Abe Y, Imabayashi E, Kuji I, Matsuda H.
Int J Clin Oncol. 2012 Jun;17(3):276-82. doi: 10.1007/s10147-011-0287-2. Epub 2011 Aug 10.
PMID:21830087

Long-term gemcitabine administration in heavily pretreated Japanese patients with metastatic breast cancer: additional safety analysis of a phase II study.
Takao S, Tokuda Y, Saeki T, Funai J, Ishii M, Takashima S.
Breast Cancer. 2012 Oct;19(4):335-42. doi: 10.1007/s12282-011-0289-y. Epub 2011 Jul 13.
PMID:21751001

Quantitative prediction of tumor response to neoadjuvant chemotherapy in breast cancer: novel marker genes and prediction model using the expression levels.
Sano H, Wada S, Eguchi H, Osaki A, Saeki T, Nishiyama M.
Breast Cancer. 2012 Jan;19(1):37-45. doi: 10.1007/s12282-011-0263-8. Epub 2011 Mar 25.
PMID:21437666

[The potential role of SPECT/CT in the preoperative detection of sentinel lymph nodes in breast cancer].
Mátrai Z, Tóth L, Saeki T, Sinkovics I, Godény M, Takeuchi H, Bidlek M, Bartal A, Sávolt A, Dorogi B, Kásler M.
Orv Hetil. 2011 Apr 24;152(17):678-88. doi: 10.1556/OH.2011.29077. Hungarian.
PMID:21464026

[Current status and future direction of postoperative adjuvant therapy in breast cancer].
Osaki A, Saeki T.
Gan To Kagaku Ryoho. 2011 Sep;38(9):1406-11. Japanese.
PMID:21918336

FOXP1, an estrogen-inducible transcription factor, modulates cell proliferation in breast cancer cells and 5-year recurrence-free survival of patients with tamoxifen-treated breast cancer.
Shigekawa T, Ijichi N, Ikeda K, Horie-Inoue K, Shimizu C, Saji S, Aogi K, Tsuda H, Osaki A, Saeki T, Inoue S.
Horm Cancer. 2011 Oct;2(5):286-97. doi: 10.1007/s12672-011-0082-6.
PMID:21901488

Usefulness of diffusion-weighted imaging of breast tumors: quantitative and visual assessment.
Inoue K, Kozawa E, Mizukoshi W, Tanaka J, Saeki T, Sakurai T, Kimura F.
Jpn J Radiol. 2011 Jul;29(6):429-36. doi: 10.1007/s11604-011-0575-9. Epub 2011 Jul 24.
PMID:21786099

Early metabolic response to neoadjuvant letrozole, measured by FDG PET/CT, is correlated with a decrease in the Ki67 labeling index in patients with hormone receptor-positive primary breast cancer: a pilot study.
Ueda S, Tsuda H, Saeki T, Omata J, Osaki A, Shigekawa T, Ishida J, Tamura K, Abe Y, Moriya T, Yamamoto J.
Breast Cancer. 2011 Oct;18(4):299-308. doi: 10.1007/s12282-010-0212-y. Epub 2010 Jul 9.
PMID:20617404

A false positive for metastatic lymph nodes in the axillary region of a breast cancer patient following mastectomy.
Fujiuchi N, Saeki T, Takeuchi H, Sano H, Takahashi T, Matsuura K, Shigekawa T, Misumi M, Nakamiya N, Okubo K, Osaki A, Sakurai T, Matsuda H.
Breast Cancer. 2011 Apr;18(2):141-4. doi: 10.1007/s12282-009-0125-9. Epub 2009 Jun 24.
PMID:19554397

Early reduction in standardized uptake value after one cycle of neoadjuvant chemotherapy measured by sequential FDG PET/CT is an independent predictor of pathological response of primary breast cancer.
Ueda S, Tsuda H, Saeki T, Osaki A, Shigekawa T, Ishida J, Tamura K, Abe Y, Omata J, Moriya T, Fukatsu K, Yamamoto J.
Breast J. 2010 Nov-Dec;16(6):660-2. doi: 10.1111/j.1524-4741.2010.01011.x. No abstract available.
PMID:21070448

Estrogen-related receptor γ modulates cell proliferation and estrogen signaling in breast cancer.
Ijichi N, Shigekawa T, Ikeda K, Horie-Inoue K, Fujimura T, Tsuda H, Osaki A, Saeki T, Inoue S.
J Steroid Biochem Mol Biol. 2011 Jan;123(1-2):1-7. doi: 10.1016/j.jsbmb.2010.09.002. Epub 2010 Sep 29.
PMID:2088378

BiClamp forceps significantly shorten the operation time for breast surgery.
Takeuchi H, Saeki T, Shigekawa T, Sano H, Nakamiya N, Matsuura K, Misumi M, Takahashi T, Fujiuchi N, Okubo K, Osaki A, Sakurai T, Koyama I.
Surg Today. 2010 Aug;40(8):706-10. doi: 10.1007/s00595-009-4118-2. Epub 2010 Jul 30.
PMID:20676852

The efficacy and safety of gemcitabine plus paclitaxel combination first-line therapy for Japanese patients with metastatic breast cancer including triple-negative phenotype.
Aogi K, Yoshida M, Sagara Y, Kamigaki S, Okazaki M, Funai J, Fujimoto T, Toi M, Saeki T, Takashima S.
Cancer Chemother Pharmacol. 2011 May;67(5):1007-15. doi: 10.1007/s00280-010-1390-1. Epub 2010 Jul 14.
PMID:20628744

[An antiemetic guideline for patients with malignancies in Japan].
Takeuchi H, Saeki T.
Gan To Kagaku Ryoho. 2010 Jun;37(6):976-979. Review. Japanese.
PMID:20567095

In vitro and in vivo anti-tumor effects of novel Span 80 vesicles containing immobilized Eucheuma serra agglutinin.
Omokawa Y, Miyazaki T, Walde P, Akiyama K, Sugahara T, Masuda S, Inada A, Ohnishi Y, Saeki T, Kato K.
Int J Pharm. 2010 Apr 15;389(1-2):157-67. doi: 10.1016/j.ijpharm.2010.01.033. Epub 2010 Jan 25.
PMID:20100554

[Tolerability and safety of docetaxel plus cyclophosphamide as adjuvant chemotherapy for axillary lymph node-negative breast cancer--JECBC04 trial].
Yamamoto N, Tabei T, Inoue K, Takei H, Sato N, Yanagita Y, Fujisawa T, Fujii H, Saeki T, Kurosumi M.
Gan To Kagaku Ryoho. 2010 Jan;37(1):57-63. Japanese.
PMID:20087033

Physiological and oncogenic Aurora-A pathway.
Saeki T, Ouchi M, Ouchi T.
Int J Biol Sci. 2009 Nov 26;5(7):758-62. Review.
PMID:20011137

Phase II study of gemcitabine monotherapy as a salvage treatment for Japanese metastatic breast cancer patients after anthracycline and taxane treatment.
Suzuki Y, Tokuda Y, Fujiwara Y, Iwata H, Sasaki Y, Saji S, Aogi K, Nambu Y, Suri A, Saeki T, Takashima S.
Jpn J Clin Oncol. 2009 Nov;39(11):699-706. doi: 10.1093/jjco/hyp103. Epub 2009 Sep 22.
PMID:19776022

Efficacy and tolerability of weekly paclitaxel in combination with high-dose toremifene citrate in patients with metastatic breast cancer.
Okita A, Saeki T, Aogi K, Osumi S, Takashima S, Okita R, Taira N, Kakishita T, Kurita A.
Acta Med Okayama. 2009 Aug;63(4):187-94.
PMID:19727203

Population pharmacokinetics of docetaxel in patients with hepatic dysfunction treated in an oncology practice.
Minami H, Kawada K, Sasaki Y, Tahara M, Igarashi T, Itoh K, Fujii H, Saeki T, Ozawa K, Sato H.
Cancer Sci. 2009 Jan;100(1):144-9. doi: 10.1111/j.1349-7006.2009.00992.x. Epub 2008 Oct 30.
PMID:19018756

Pharmacokinetic analysis of a combined chemoendocrine treatment with paclitaxel and toremifene for metastatic breast cancer.
Saeki T, Okita A, Aogi K, Kakishita T, Okita R, Taira N, Ohama Y, Takashima S, Nishikawa K.
Breast Cancer. 2009;16(2):113-20. doi: 10.1007/s12282-008-0075-7. Epub 2008 Oct 21.
PMID:18936884

Expression level of enzymes related to in situ estrogen synthesis and clinicopathological parameters in breast cancer patients.
Suzuki M, Ishida H, Shiotsu Y, Nakata T, Akinaga S, Takashima S, Utsumi T, Saeki T, Harada N.
J Steroid Biochem Mol Biol. 2009 Feb;113(3-5):195-201. doi: 10.1016/j.jsbmb.2008.12.008. Epub 2008 Dec 30.
PMID:19159687

Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II and pharmacokinetic study in Japan.
Tokudome N, Ito Y, Hatake K, Toi M, Sano M, Iwata H, Sato Y, Saeki T, Aogi K, Takashima S.
Anticancer Drugs. 2008 Aug;19(7):753-9. doi: 10.1097/CAD.0b013e328302eb15.
PMID:18594220

Successful treatment of leptomeningeal metastases from breast cancer using the combination of trastuzumab and capecitabine: a case report.
Shigekawa T, Takeuchi H, Misumi M, Matsuura K, Sano H, Fujiuchi N, Okubo K, Osaki A, Aogi K, Saeki T.
Breast Cancer. 2009;16(1):88-92. doi: 10.1007/s12282-008-0056-x. Epub 2008 May 14.
PMID:18478315

No increase of breast cancer incidence in Japanese women who received hormone replacement therapy: overview of a case-control study of breast cancer risk in Japan.
Saeki T, Sano M, Komoike Y, Sonoo H, Honjyo H, Ochiai K, Kobayashi T, Aogi K, Sato N, Sawai S, Miyoshi Y, Takeuchi M, Takashima S.
Int J Clin Oncol. 2008 Feb;13(1):8-11. doi: 10.1007/s10147-007-0728-0. Epub 2008 Feb 29. Erratum in: Int J Clin Oncol. 2008 Jun;13(3):279. Miyoshi, Yoshio [corrected to Miyoshi, Yasuo].
PMID:18307013

Serum p53 antibodies as an early detection marker in colorectal cancer.
Takeda A, Shimadai H, Iseki H, Saeki T, Koyama I.
Hepatogastroenterology. 2007 Sep;54(78):2 pages preceeding table of content. No abstract available.
PMID:18019675

[Future direction of adjuvant chemotherapy for breast cancer following new risk categories of St. Gallen Consensus].
Osaki A, Saeki T.
Nihon Rinsho. 2007 Jun 28;65 Suppl 6:407-13. Review. Japanese. No abstract available.
PMID:17682185

[Medical treatment for older breast cancer patients].
Osaki A, Saeki T.
Gan To Kagaku Ryoho. 2007 Mar;34(3):374-9. Japanese.
PMID:17353627